Loss of BRG1 (SMARCA4) Immunoexpression in a Pediatric Non-Central Nervous System Tumor Cohort
Open Access
- 12 August 2019
- journal article
- research article
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 23 (2) , 132-138
Abstract
Malignant rhabdoid tumors and atypical teratoid/rhabdoid tumors of the central nervous system are primitive malignancies associated with a poor prognosis. These tumors have previously been characterized by inactivation of the switch/sucrose nonfermenting (SWI/SNF) chromatin remodeling complex protein integrase interactor 1 (INI1), encoded by the SMARCB1 gene. In the last decade, sporadic publications have shown that a different SWI/SNF protein, brahma-related gene 1 (BRG1), encoded by the SMARCA4 gene, is associated with a similar rhabdoid phenotype and possible germline mutation termed rhabdoid tumor predisposition syndrome type 2. We sought to determine the presence of BRG1 expression in pediatric embryonal tumors. Using a local tissue microarray consisting of 28 tumors diagnosed as having an undifferentiated, polyphenotypic, or rhabdoid morphology, expression of BRG1 by immunohistochemistry was performed. Four cases showed loss of INI1, while 3 of the remaining 24 cases demonstrated loss of BRG1. Two cases were diagnosed as soft tissue sarcomas, and 1 case was diagnosed as a small cell carcinoma of the ovary, hypercalcemic type. Survival ranged from less than 6 months after diagnosis to more than 5 years at the time of last follow-up. In conclusion, we demonstrate that BRG1 immunohistochemistry is a useful second-line immunostain for the workup of undifferentiated, polyphenotypic or rhabdoid pediatric tumors that demonstrate retained expression of INI1.Keywords
This publication has 27 references indexed in Scilit:
- SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomasNature Genetics, 2015
- EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitorsNature, 2015
- Rhabdoid Tumor Predisposition SyndromePediatric and Developmental Pathology, 2015
- SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosisActa Neuropathologica, 2014
- No small surprise – small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumourThe Journal of Pathology, 2014
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancyNature Genetics, 2013
- Nonsense Mutation and Inactivation of SMARCA4 (BRG1) in an Atypical Teratoid/Rhabdoid Tumor Showing Retained SMARCB1 (INI1) ExpressionAmerican Journal of Surgical Pathology, 2011
- Loss of SMARCB1/INI1 expression in poorly differentiated chordomasActa Neuropathologica, 2010
- Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition SyndromeThe American Journal of Human Genetics, 2010
- BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcriptionNature, 1993